# Avant Bio

Avant Bio is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, United States
- **Founded:** 2023
- **Assets under management:** Undisclosed
- **Website:** www.avant.bio
- **LinkedIn:** https://www.linkedin.com/company/avant-bio-llc

## Regulatory record

- **CRD number:** 327673
- **SEC file number:** 802-128768
- **Registration status:** Exempt Reporting Adviser — not registered with the SEC
- **Reports private funds:** Yes

## About

AVANT BIO partners with visionaries at the intersection of advanced technologies and novel therapeutics, investing in companies delivering cutting-edge technologies to advance game-changing therapeutics. The firm focuses on Therapeutic Enabling Technologies, Biomanufacturing Tools & Automation, Machine Learning and AI Applications, Healthtech, Techbio, and Contract Services. It actively partners with entrepreneurs to maximize value creation, providing connections, deep expertise, and long-term guidance.

## Sectors

- Therapeutic Enabling Technologies
- Biomanufacturing Tools & Automation
- Machine Learning and AI Applications
- Healthtech
- Techbio
- Contract Services

## People

- Daniella Kranjac — Founding GP
- Ole Henrik Bang-Andreasen — Partner
- Sebastien Latapie — Partner
- Maik W. Jornitz — Operating Advisor
- Lukas Utiger — Operating Advisor
- Peter Lee

## Related profiles

- [Avantax Planning Partners](https://altss.com/profile/avantax-planning-partners)
- [Avant Blockchain Capital](https://altss.com/profile/avant-blockchain-capital)

---

Updated: 2026-08-11T15:06:13.093Z

Canonical page: https://altss.com/profile/avant-bio

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology